MVT-602
In human trialsMeasured in people, not heightBy injectionPeptide
A longer-lasting synthetic version of the puberty-switch peptide, built for fertility treatment, which reached mid-stage trials and stopped.
A kisspeptin receptor agonist, formerly TAK-448, with a longer action than the native peptide. Developed for assisted reproduction and never tested for growth. Phase 2 is as far as it went: the registered TAK-448 trials are terminated and no phase 3 was started.
Risks. Reported as well tolerated in two small trials in women. It is not approved, and it was never tested for growth.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.